Acute neuroinflammation in Lewis rats - A model for acute multiple sclerosis relapses

Journal of Neuroimmunology

Volumn 213, Issue 1-2, 2009, Pages 84-90

  Schneider, Claudia ^a   Schuetz, Gunnar ^a   Zollner, Thomas M ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Experimental allergic encephalomyelitis; ICAM 1; Inflammation; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GELATINASE A; INTERCELLULAR ADHESION MOLECULE 1; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOLOGICAL PARAMETERS; LEWIS RAT; MACROPHAGE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPINAL CORD LESION;

ACUTE DISEASE; ANIMALS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELITIS; NEURAL CELL ADHESION MOLECULES; RATS; RATS, INBRED LEW; SPINAL CORD;

EID: 68049137618     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.05.015     Document Type: Article

References (56)

1. Baeten K., Hendriks J.J., Hellings N., Theunissen E., Vanderlocht J., Ryck L.D., Gelan J., Stinissen P., and Adriaensens P. Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. J. Neuroimmunol. 195 (2008) 1-6
2. Ben-Hur T., Ben-Yosef Y., Mizrachi-Kol R., Ben-Menachem O., and Miller A. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J. Neuroimmunol. 175 (2006) 12-18
3. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75 (1997) 165-173
4. Berger C., Hiestand P., Kindler-Baumann D., Rudin M., and Rausch M. Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage. NMR Biomed. 19 (2006) 101-107
5. Consiglio A.R., and Lucion A.B. Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats. Brain Res. Brain Res. Protoc. 5 (2000) 109-114
6. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
7. dos Santos A.C., Barsante M.M., Arantes R.M., Bernard C.C., Teixeira M.M., and Carvalho-Tavares J. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study. J. Neuroimmunol. 162 (2005) 122-129
8. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural Transm. 113 (2006) 477-485
9. Glabinski A.R., Tuohy V.K., and Ransohoff R.M. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5 (1998) 166-171
10. Godiska R., Chantry D., Dietsch G.N., and Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58 (1995) 167-176
11. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
12. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., Kamoun M., and Rostami A. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169 (2002) 7104-7110
13. Griffiths T.D., and Newman P.K. Steroids in multiple sclerosis. J. Clin. Pharm. Ther. 19 (1994) 219-222
14. Kassiotis G., Pasparakis M., Kollias G., and Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur. J. Immunol. 29 (1999) 774-780
15. Kim G., Kohyama K., Tanuma N., Arimito H., and Matsumoto Y. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE. J. Immunol. 161 (1998) 6993-6998
16. Klinkert W.E., Kojima K., Lesslauer W., Rinner W., Lassmann H., and Wekerle H. TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72 (1997) 163-168
17. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
18. Lee S.J., and Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98 (1999) 77-88
19. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., Simmons D., and Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell. Biol. 142 (1998) 117-127
20. Naik U.P., and Eckfeld K. Junctional adhesion molecule 1 (JAM-1). J. Biol. Regul. Homeost. Agents 17 (2003) 341-347
21. Ostermann G., Weber K.S., Zernecke A., Schroder A., and Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3 (2002) 151-158
22. Owens, T., Tran, E., Hassan-Zahraee, M., Krakowski, M., 1998. Immune cell entry to the CNS-a focus for immunoregulation of EAE. Res Immunol 149, 781-789; discussion 844-786, 855-760.
23. Padden M., Leech S., Craig B., Kirk J., Brankin B., and McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol. 113 (2007) 177-186
24. Peterson J.W., Bo L., Mork S., Chang A., Ransohoff R.M., and Trapp B.D. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 61 (2002) 539-546
25. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98 (1999) 57-68
26. Ransohoff R.M. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. Trends Immunol. 27 (2006) 167-168
27. Reichardt H.M., Gold R., and Luhder F. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev. Neurother. 6 (2006) 1657-1670
28. Rizvi S.A., and Bashir K. Other therapy options and future strategies for treating patients with multiple sclerosis. Neurology 63 (2004) S47-54
29. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., and Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172 (1990) 1193-1200
30. Saini A., Al-Shanti N., and Stewart C.E. Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 17 (2006) 475-486
31. Schacke H., Schottelius A., Docke W.D., Strehlke P., Jaroch S., Schmees N., Rehwinkel H., Hennekes H., and Asadullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 227-232
32. Schacke, H., Zollner, T.M., Docke, W.D., Rehwinkel, H., Jaroch, S., Skuballa, W., Neuhaus, R., May, E., Zügel, U., Asadullah, K., in press. Characterization of 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br. J. Pharmacol.
33. Schaecher K., Rocchini A., Dinkins J., Matzelle D.D., and Banik N.L. Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease. J. Neuroimmunol. 129 (2002) 1-9
34. Schmidt J., Gold R., Schonrock L., Zettl U.K., Hartung H.P., and Toyka K.V. T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123 Pt 7 (2000) 1431-1441
35. Selmaj K., Raine C.S., Cannella B., and Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87 (1991) 949-954
36. Selmaj K., Papierz W., Glabinski A., and Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56 (1995) 135-141
37. Sharief M.K., and Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325 (1991) 467-472
38. Sipkins D.A., Gijbels K., Tropper F.D., Bednarski M., Li K.C., and Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J. Neuroimmunol. 104 (2000) 1-9
39. Smith K.J., and Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1 (2002) 232-241
40. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
41. Spiegelman B.M., and Hotamisligil G.S. Through thick and thin: wasting, obesity, and TNF alpha. Cell 73 (1993) 625-627
42. Spuler S., Yousry T., Scheller A., Voltz R., Holler E., Hartmann M., Wick M., and Hohlfeld R. Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J. Neuroimmunol. 66 (1996) 57-64
43. Sriram S., and Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58 (2005) 939-945
44. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2 (2001) 762-764
45. Steinman L., and Zamvil S.S. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol. 26 (2005) 565-571
46. Stromnes I.M., and Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1 (2006) 1810-1819
47. Stromnes I.M., and Goverman J.M. Passive induction of experimental allergic encephalomyelitis. Nat. Protoc. 1 (2006) 1952-1960
48. Swanborg R.H., and Stepaniak J.A. Experimental autoimmune encephalomyelitis in the rat. Curr. Protoc. Immunol. (2001) Chapter 15, Unit 15 12
49. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53 (1999) 457-465
50. Turrin N.P., and Rivest S. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26 (2006) 143-151
51. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., Woody J.N., Hartung H.P., and Polman C.H. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47 (1996) 1531-1534
52. Weiller C., May A., Sach M., Buhmann C., and Rijntjes M. Role of functional imaging in neurological disorders. J. Magn. Reson. Imaging 23 (2006) 840-850
53. Willenborg D.O., Staykova M., Fordham S., O'Brien N., and Linares D. The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 191 (2007) 16-25
54. Williams L.A., Martin-Padura I., Dejana E., Hogg N., and Simmons D.L. Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol. Immunol. 36 (1999) 1175-1188
55. Wolburg H., Wolburg-Buchholz K., and Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol. 109 (2005) 181-190
56. Yeung D., Manias J.L., Stewart D.J., and Nag S. Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol. 115 (2008) 635-642